A Concise Route to Orthogonally Protected Bulgecinine

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Structural Biology

Background:

• Bulgecinine is the core scaffold for inhibitors targeting bacterial lytic transglycosylases.
• These enzymes are crucial for maintaining bacterial cell-envelope homeostasis.
• The pyrrolidine ring of bulgecinine mimics a key intermediate in the enzymatic reaction.

Purpose of the Study:

• To develop a concise and efficient synthetic route to protected bulgecinine.
• To establish a reliable method for accessing this important structural motif for drug discovery.

Main Methods:

• A nine-step linear synthesis was employed.
• The key transformation involved a vinyl Grignard addition to a pyrrolidine-N-oxide intermediate.
• Stereochemistry was confirmed using X-ray crystallography.

Main Results:

• Protected bulgecinine (compound 9) was synthesized in 12% overall yield.
• The synthesis established the correct absolute stereochemistry at three chiral centers.
• X-ray structure analysis validated the compound's stereochemistry.

Conclusions:

• A concise synthetic strategy for bulgecinine has been successfully developed.
• This synthesis provides a valuable route to a key component for developing novel antibacterial agents.
• The validated stereochemistry is critical for the design of potent enzyme inhibitors.